Importance of good manufacturing practices in microbiological monitoring in processing human tissues for transplant
Tóm tắt
Skin allografts represent an important therapeutic resource in the treatment of severe skin loss. The risk associated with application of processed tissues in humans is very low, however, human material always carries the risk of disease transmission. To minimise the risk of contamination of grafts, processing is carried out in clean rooms where air quality is monitored. Procedures and quality control tests are performed to standardise the production process and to guarantee the final product for human use. Since we only validate and distribute aseptic tissues, we conducted a study to determine what type of quality controls for skin processing are the most suitable for detecting processing errors and intercurrent contamination, and for faithfully mapping the process without unduly increasing production costs. Two different methods for quality control were statistically compared using the Fisher exact test. On the basis of the current study we selected our quality control procedure based on pre- and post-processing tissue controls, operator and environmental controls. Evaluation of the predictability of our control methods showed that tissue control was the most reliable method of revealing microbial contamination of grafts. We obtained 100 % sensitivity by doubling tissue controls, while maintaining high specificity (77 %).
Tài liệu tham khảo
CNT, WHO, SOHO V&S project (2011) Working group 2—other tissues. In: Notify. Exploring vigilance notification for organs, tissues and cells. A global consultation. Compositori Ed. Bologna pp 38–39
Commission Directive 2004/23/EC of the European Parliament and Council on quality and safety standards for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells
Commission Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells
Commission Directive 2006/86/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells
Csonge L, Pellet S, Szenes A, István J (1995) Antibiotics in the preservation of allograft and xenograft skin. Burns 21:102–105
Eastlund T (2006) Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Banking 7:147–166
EU guidelines to good manufacturing practice medicinal products for human and veterinary use—Annex 1, Ed. 2008
Kagan RJ, Robb EC, Plessinger RT (2005) Human skin banking. Clin Lab Med 25:587–605
Kearney JN (2005) Guidelines on processing and clinical use of skin allografts. Clin Dermatol 23:357–364
Linee guida per il prelievo, la processazione e la distribuzione di tessuti a scopo di trapianto—Centro Nazionale Trapianti ed. 2007
Mackie DP (1997) The Euro Skin Bank: development and application of glycerol-preserved allografts. J Burn Care Rehabil 18:S7–S9
Mathur M, De A, Gore M (2009) Microbiological assessment of cadaver skin grafts received in a skin bank. Burns 35:104–106
May SR, Wainwringht JF, DeClement FA (1985) Variables determining the amount of microbial contamination on cadaveric allograft skin used as a biological wound dressing. Burns 11:242–251
Monafo WW, Tandon SN, Bradley RE, Condict C (1976) Bacterial contamination of skin used as a biological dressing. A potential hazard. JAMA 235:1248–1249
Obeng MK, McCauley RL, Barnett JR, Heggers JP, Sheridan K, Schutzler SS (2001) Cadaveric allograft discards as a result of positive skin cultures. Burns 27:267–271
Perry A, Lambert P (2011) Propionibacterium acnes: infection beyond the skin. Expert Rev Anti Infect Ther 9:1149–1156
Pianigiani E, Ierardi F, Cuciti C, Brignali S, Oggioni M, Fimiani M (2010) Processing efficacy in relation to microbial contamination of skin allografts from 723 donors. Burns 36:347–351
Pirnay JP, Verween G, Pascual B, Verbeken G, De Corte P, Rose T et al (2012) Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures. Cell Tissue Bank 13:287–295
Vicentino M, Rodriguez G, Saldias M, Alvarez I (2009) Guidelines to implement quality management systems in microbiology laboratories for tissue banking. Transplant Proc 41:3481–3484
Vuola J, Pipping D (2002) Maintaining a glycerolized skin bank—a practical approach. Burns 28:S31–S33